The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)

Filter results
Date Title PDF
24/04/2018 ROVI announces the agreement with Hikma to distribute and market its Enoxaparin biosimilar
20/02/2018 2017 Results press release
20/02/2018 2017 Results presentation